<DOC>
	<DOCNO>NCT00118807</DOCNO>
	<brief_summary>The purpose trial compare effectiveness three combination treatment uncomplicated malaria give operational setting , without supervision dos first dose .</brief_summary>
	<brief_title>Trial Effectiveness AQ/AS , SP/AQ SP/CQ Uncomplicated Malaria Gambian Children</brief_title>
	<detailed_description>Children age 0.5-10 year present health centre fever history fever symptom suggestive malaria screen ; child find uncomplicated Plasmodium falciparum malaria randomize receive treatment AS/AQ , SP/AQ SP/CQ . A drug dispenser supervise first dose medication subsequent dos give child â€™ parent administer home , unsupervised study team . Patients visit home three day later . Unused medication count mother ask number dos child receive side effect . Children see 2 4 week treatment collect finger prick sample pack cell volume ( PCV ) malaria microscopy . The primary endpoint clinical failure day 28 . Analysis intention treat .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Fanasil , pyrimethamine drug combination</mesh_term>
	<mesh_term>Artesunate</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<mesh_term>Sulfadoxine</mesh_term>
	<mesh_term>Amodiaquine</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<criteria>Presentation health centre febrile illness Monoinfection P. falciparum Parasitaemia &gt; =500/microlitre Fever history fever Signs severe complicate malaria ( persistent vomit without dehydration , history convulsion present illness , inability sit stand , parasitaemia &gt; 200,000/ul ) Severe malnutrition Clinically evident concomitant disease PCV &lt; 20 % History allergy study medication Residence outside study area hence difficult follow</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>June 2003</verification_date>
	<keyword>malaria treatment</keyword>
	<keyword>artemisinin base combination therapy</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>pragmatic trial</keyword>
	<keyword>effectiveness</keyword>
</DOC>